TC
VCYT icon

TFS Capital’s Veracyte VCYT Stock Holding History

TFS Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100,467
Closed -$837K – 349
2017
Q2 		$837K Sell
100,467
-7,054
-7% -$57.5K 0.33% 96
2017
Q1 		$987K Buy
107,521
+96,784
+901% +$792K 0.32% 103
2016
Q4 		$83K Buy
+10,737
New +$80.3K 0.02% 657
2015
Q1 		– Sell
-13,001
Closed -$126K – 1140
2014
Q4 		$126K Sell
13,001
-17,769
-58% -$139K 0.01% 890
2014
Q3 		$300K Buy
+30,770
New +$404K 0.03% 745

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TFS Capital's VCYT Position: Q3 2017 in Review

TFS Capital sold out of Veracyte (VCYT) in Q3 2017, closing a stake of 100,467 shares — an estimated $837K sold.

TFS Capital first reported a position in VCYT in Q3 2014 and held it in 5 quarters. The position peaked at $987K in Q1 2017. 87 funds tracked by Wall St. Rank hold VCYT as of Q3 2017.

  • TFS Capital reported no remaining Veracyte position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 100,467 Veracyte shares in Q3 2017, an estimated $837K.
  • TFS Capital first reported a position in Veracyte in Q3 2014 and held it in 5 quarters.
  • TFS Capital's Veracyte position peaked at $987K in Q1 2017.
  • 87 funds tracked by Wall St. Rank held Veracyte as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.